{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:27:42Z","timestamp":1790638062917,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Resorcinol Task Force"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.yrtph.2016.06.019","type":"journal-article","created":{"date-parts":[[2016,6,25]],"date-time":"2016-06-25T23:37:49Z","timestamp":1466897869000},"page":"283-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-9607","authenticated-orcid":false,"given":"Kozo","family":"Motonaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-8303","authenticated-orcid":false,"given":"Mika","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Odawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Welsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2016.06.019_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0892-0362(89)90056-1","article-title":"Neurological consequences of congenital hypothyroidism in fischer 344 rats","volume":"11","author":"Albee","year":"1989","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/10915818609141929","article-title":"Final report on the safety assessment of 2-methylresorcinol and resorcinol","volume":"5","author":"American College of Toxicology","year":"1986","journal-title":"Am.. Coll. Toxicol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/thy.2008.0341","article-title":"Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation","volume":"19","author":"Berbel","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.yrtph.2016.06.019_bib4","first-page":"319","article-title":"L\u2019hypothyroidie induite par la resorcine (Hypothyroidism induced by resorcinol)","volume":"230","author":"Berthezene","year":"1973","journal-title":"Lyon Med."},{"key":"10.1016\/j.yrtph.2016.06.019_bib5","first-page":"449","article-title":"Fall von t\u00f6dlicher resorzinvergiftung bei \u00e4u\u00dferlicher anwendung des mittels","volume":"60","author":"Boeck","year":"1915","journal-title":"Dermatol. Wochenschr."},{"key":"10.1016\/j.yrtph.2016.06.019_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(50)90689-1","article-title":"Myxedema from resorcinol ointment applied to leg ulcers","volume":"1","author":"Bull","year":"1950","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2016.06.019_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/07435808709023659","article-title":"Rat thyroid peroxidase (TPO) biosynthesis in\u00a0vitro: studies using antiserum to porcine TPO","volume":"13","author":"Cooper","year":"1987","journal-title":"Endocr. Res."},{"key":"10.1016\/j.yrtph.2016.06.019_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.yrtph.2016.06.019_bib9","series-title":"The Role of Thyroid Hormones in Neurodevelopment: Using the Adverse Action Pathway Concept to Focus Research Strategies","author":"Crofton","year":"2012"},{"key":"10.1016\/j.yrtph.2016.06.019_bib10","doi-asserted-by":"crossref","first-page":"9668","DOI":"10.1021\/bi00198a036","article-title":"Mechanism-based inactivation of lactoperoxidase and thyroid peroxidase by resorcinol derivatives","volume":"33","author":"Divi","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.yrtph.2016.06.019_bib11","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1021\/bi00364a041","article-title":"Mechanism-based inhibition of lactoperoxidase by thiocarbamide goitrogens","volume":"25","author":"Doerge","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.yrtph.2016.06.019_bib12","first-page":"146","article-title":"The goitrogenic action of resorcinol in rats","volume":"14","author":"Doniach","year":"1953","journal-title":"Br. J. Expt. Pathol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib13","first-page":"CD008633","article-title":"Interventions for preventing and treating hyperthyroidism in pregnancy","volume":"9","author":"Earl","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.yrtph.2016.06.019_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.freeradbiomed.2006.02.023","article-title":"Protein radical formation on thyroid peroxidase during turnover as detected by immuno-spin trapping","volume":"41","author":"Ehrenshaft","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yrtph.2016.06.019_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF01957719","article-title":"Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero","volume":"151","author":"Eisenstein","year":"1992","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.yrtph.2016.06.019_bib16","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/0006-2952(82)90296-9","article-title":"Mechanism of inactivation of thyroid peroxidase by thioureylene drugs","volume":"31","author":"Engler","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib17","volume":"I","author":"Everse","year":"1990"},{"key":"10.1016\/j.yrtph.2016.06.019_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.reprotox.2012.05.096","article-title":"Feasibility of the extended one-generation reproductive toxicity study (OECD 443)","volume":"34","author":"Fegert","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1476-5381.1955.tb00050.x","article-title":"The mode of action of antithyroid drugs: further observations on in\u00a0vitro inhibition of oxidative protein iodination","volume":"10","author":"Fraser","year":"1955","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.yrtph.2016.06.019_bib20","first-page":"295","article-title":"Endemic goiter in western Columbia","volume":"2","author":"Gaitan","year":"1983","journal-title":"Ecol. Dis."},{"key":"10.1016\/j.yrtph.2016.06.019_bib21","first-page":"176","article-title":"Resorcinol: final goitrogenic product in water from a goitrogenic well","volume":"5","author":"Gaitan","year":"1987","journal-title":"Clin. Ecol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/taap.1995.1209","article-title":"Effects of developmental hypothyroidism on auditory and motor function in the rat","volume":"135","author":"Goldey","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib23","first-page":"199","article-title":"\u00c9tude Clinique et biologique d\u2019un goiter \u00e0 la r\u00e9sorcine","volume":"28","author":"Guinet","year":"1967","journal-title":"Ann. d\u2019Endocrinologie"},{"key":"10.1016\/j.yrtph.2016.06.019_bib24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1701-2163(16)35438-X","article-title":"The safety of methimazole and propylthiouracil in pregnancy: a systematic review","volume":"34","author":"Hackmon","year":"2012","journal-title":"J.\u00a0Obstet. Gynaecol. Can."},{"key":"10.1016\/j.yrtph.2016.06.019_bib25","first-page":"14","article-title":"Do thyroid disrupting chemicals influence foetal development during pregnancy?","author":"Hartoft-Nielsen","year":"2011","journal-title":"J.\u00a0Thyroid. Res."},{"key":"10.1016\/j.yrtph.2016.06.019_bib26","first-page":"164","article-title":"Varicose ulceration of the legs and myxoedema and goiter following application of resorcinol ointment","volume":"10","author":"Hobson","year":"1951","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.yrtph.2016.06.019_bib27","series-title":"RESORCINOL, Concise International Chemical Assessment Document 71","author":"IPCS","year":"2006"},{"key":"10.1016\/j.yrtph.2016.06.019_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-86-4-447","article-title":"Resorcinol induced hypothyroidism in a patient on chronic hemodialysis","volume":"86","author":"Katin","year":"1977","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.yrtph.2016.06.019_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0272-0590(87)90023-6","article-title":"Comparative metabolism and excretion of resorcinol in male and female F344 rats","volume":"9","author":"Kim","year":"1987","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib30","first-page":"849","article-title":"Acute medicinal resorcinol poisoning","volume":"91","author":"Klem","year":"1930","journal-title":"Nor. Mag. Laegev"},{"key":"10.1016\/j.yrtph.2016.06.019_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/15287399209531686","article-title":"Antithyroid effects of coal-derived pollutants","volume":"37","author":"Lindsay","year":"1992","journal-title":"J.\u00a0Toxicol. Environ. Health"},{"key":"10.1016\/j.yrtph.2016.06.019_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/rtph.2002.1585","article-title":"Toxicology review and risk assessment of resorcinol: thyroid effects","volume":"36","author":"Lynch","year":"2002","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib33","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1021\/ar4001229","article-title":"Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action","volume":"46","author":"Manna","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.yrtph.2016.06.019_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/endo-91-3-747","article-title":"The thyroidal accumulation, oxidation and metabolic fate of 35S-methimazole in the rat","volume":"91","author":"Marchant","year":"1972","journal-title":"Endocrinology"},{"key":"10.1016\/j.yrtph.2016.06.019_bib35","first-page":"305","article-title":"Antithyroid drugs","volume":"3","author":"Marchant","year":"1978","journal-title":"Pharmac. Ther. B"},{"key":"10.1016\/j.yrtph.2016.06.019_bib36","first-page":"367","article-title":"Pharmacokinetics of resorcinol in the rat","volume":"38","author":"Merker","year":"1982","journal-title":"Res. Comm. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib37","first-page":"3975","article-title":"Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia?","volume":"85","author":"Morreale de Escobar","year":"2000","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yrtph.2016.06.019_bib38","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yrtph.2016.06.019_bib39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-4362.1978.tb05977.x","article-title":"Systemic reaction to topically applied drugs","volume":"17","author":"Pascher","year":"1978","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx400310w","article-title":"Development of a thyroperoxidase inhibition assay for high-throughput screening","volume":"27","author":"Paul","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib41","doi-asserted-by":"crossref","first-page":"8440","DOI":"10.1073\/pnas.83.22.8440","article-title":"Absolute electronegativity and hardness correlated with molecular orbital theory","volume":"83","author":"Pearson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yrtph.2016.06.019_bib42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000355288","article-title":"Se- and s-based thiouracil and methimazole analogues exert different inhibitory mechanisms on type 1 and type 2 deiodinases","volume":"2","author":"Rijntjes","year":"2013","journal-title":"Eur. Thyroid. J."},{"key":"10.1016\/j.yrtph.2016.06.019_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1687-9856-2009-132041","article-title":"Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use","volume":"2009","author":"Rivkees","year":"2009","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2009.03495.x","article-title":"Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study","volume":"68","author":"Rosenfeld","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib45","series-title":"Evaluation of Human Health Data on Resorcinol; Resorcinol Task Force (RTF) Technical Report","author":"RTF","year":"2014"},{"key":"10.1016\/j.yrtph.2016.06.019_bib46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0022-3565(25)29357-0","article-title":"Propylthiouracil: absorption, metabolism and excretion in the albino rat","volume":"183","author":"Sitar","year":"1972","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2016.06.019_bib47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0022-3565(25)29428-9","article-title":"Methimazole: absorption, metabolism and excretion in the albino rat","volume":"184","author":"Sitar","year":"1973","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yrtph.2016.06.019_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archderm.1943.01510040037007","article-title":"Studies on ointments: V. Ointments containing resorcinol","volume":"48","author":"Strakosch","year":"1943","journal-title":"Arch. Dermatol.. Syphilol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib49","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2133.1961.tb14401.x","article-title":"Exogenous ochronosis and myxoedema from resorcinol","volume":"73","author":"Thomas","year":"1961","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib50","series-title":"U.S. National Library of Medicine","author":"TOXNET ChemIDplus database","year":"2014"},{"key":"10.1016\/j.yrtph.2016.06.019_bib51","unstructured":"US-FDA, 2016. (PTU)http:\/\/www.accessdata.fda.gov\/spl\/data\/46a544f6-f4a1-4877-a07a-484a42c84644\/46a544f6-f4a1-4877-a07a-484a42c84644.xml (MMI)http:\/\/www.accessdata.fda.gov\/spl\/data\/d4bf45c5-6b50-430a-84e6-c3d62fd2a9cf\/d4bf45c5-6b50-430a-84e6-c3d62fd2a9cf.xml."},{"key":"10.1016\/j.yrtph.2016.06.019_bib52","series-title":"Toxicology and Carcinogenesis Studies of Resorcinol (CAS No.108-46-3) in F344\/N Rats and B6C3F1 Mice (Gavage Studies)","first-page":"235","author":"US-NTP","year":"1992"},{"key":"10.1016\/j.yrtph.2016.06.019_bib53","series-title":"Two-generation Reproduction Toxicity Study of Propylthiouracil (CAS#51-52-5) when Administered to Sprague-dawley Rats in the Drinking Water","author":"US-NTP","year":"2003"},{"key":"10.1016\/j.yrtph.2016.06.019_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/10915810701876687","article-title":"Routes and modes of administration of resorcinol and their relationship to potential manifestations of thyroid gland toxicity in animals and man","volume":"27","author":"Welsch","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/10915810701876679","article-title":"Two-generation reproductive toxicity study of resorcinol administered via drinking water to Crl:CD(SD) rats","volume":"27","author":"Welsch","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib56","series-title":"Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination; a Guide for Programme Managers","author":"WHO","year":"2007"},{"key":"10.1016\/j.yrtph.2016.06.019_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-4362.1983.tb02149.x","article-title":"Percutaneous absorption, blood levels, and urinary excretion of resorcinol applied topically in humans","volume":"22","author":"Yeung","year":"1983","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.yrtph.2016.06.019_bib58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/10408440591007313","article-title":"Mode of action: developmental thyroid hormone insufficiency\u2013neurological abnormalities resulting from exposure to propylthiouracil","volume":"35","author":"Zoeller","year":"2005","journal-title":"Crit. Rev. Toxicol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230016301775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230016301775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:29:03Z","timestamp":1759494543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230016301775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":58,"alternative-id":["S0273230016301775"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2016.06.019","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2016.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}